S J Billups, B L Carter. Show Affiliations »
Abstract
Mesh: See more » Benzimidazoles/adverse effectsBenzimidazoles/therapeutic useCalcium Channel Blockers/adverse effectsCalcium Channel Blockers/therapeutic useDrug ApprovalHumansMibefradilProduct Surveillance, PostmarketingTetrahydronaphthalenes/adverse effectsTetrahydronaphthalenes/therapeutic use
Substances: See more » BenzimidazolesCalcium Channel BlockersTetrahydronaphthalenesMibefradil
Year: 1998 PMID: 9681103 DOI: 10.1345/aph.17356
Source DB: PubMed Journal: Ann Pharmacother ISSN: 1060-0280 Impact factor: 3.154